Douty; Brent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Douty; Brent.The latest application filed is for "heterocyclic compounds as pi3k-y inhibitors".

Company Profile

17.17.27

Douty; Brent - Fallowfield PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclylamines as PI3K inhibitors Grant 11,433,071 - Li , et al. September 6, 2	2022-09-06
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20220251087 - Buesking; Andrew W. ; et al.	2022-08-11
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20220213107 - Douty; Brent ; et al.	2022-07-07
Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220169649 - Ai; Yanran ; et al.	2022-06-02
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20220119393 - Li; Yun-Long ; et al.	2022-04-21
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor App 20220112198 - Douty; Brent ; et al.	2022-04-14
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20220106318 - Li; Yun-Long ; et al.	2022-04-07
Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220064165 - Liu; Kai ; et al.	2022-03-03
Tertiary alcohols as PI3K-.gamma. inhibitors Grant 11,225,486 - Douty , et al. January 18, 2	2022-01-18
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor Grant 11,186,580 - Douty , et al. November 30, 2	2021-11-30
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20210332059 - Li; Yun-Long ; et al.	2021-10-28
Aminopyrazine derivatives as PI3K-.gamma. inhibitors Grant 11,046,658 - Douty , et al. June 29, 2	2021-06-29
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors Grant 10,975,088 - Buesking , et al. April 13, 2	2021-04-13
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20200385392 - Douty; Brent ; et al.	2020-12-10
Heterocyclylamines As Pi3k Inhibitors App 20200323858 - Li; Yun-Long ; et al.	2020-10-15
Tertiary alcohols as PI3K-.gamma. inhibitors Grant 10,738,057 - Douty , et al. A	2020-08-11
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20200102315 - Buesking; Andrew W. ; et al.	2020-04-02
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor App 20200071335 - Douty; Brent ; et al.	2020-03-05
AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS App 20200002295 - Douty; Brent ; et al.	2020-01-02
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors Grant 10,479,795 - Buesking , et al. Nov	2019-11-19
Heterocyclylamines As Pi3k Inhibitors App 20190298724 - Sparks; Richard B. ; et al.	2019-10-03
Heterocyclylamines as PI3K inhibitors Grant 10,376,513 - Sparks , et al. A	2019-08-13
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20190152975 - Douty; Brent ; et al.	2019-05-23
Heterocyclylamines As Pi3k Inhibitors App 20190134040 - Li; Yun-Long ; et al.	2019-05-09
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20190119287 - Buesking; Andrew W. ; et al.	2019-04-25
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20190040067 - Li; Yun-Long ; et al.	2019-02-07
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-.gamma. inhibitors Grant 10,138,248 - Buesking , et al. Nov	2018-11-27
Heterocyclylamines as PI3K inhibitors Grant 10,092,570 - Li , et al. October 9, 2	2018-10-09
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders Grant 9,932,341 - Li , et al. April 3, 2	2018-04-03
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors Grant 9,918,990 - Yue , et al. March 20, 2	2018-03-20
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20180009816 - Buesking; Andrew W. ; et al.	2018-01-11
Heterocyclylamines As Pi3k Inhibitors App 20170340641 - Li; Yun-Long ; et al.	2017-11-30
Heterocyclylamines as PI3K inhibitors Grant 9,730,939 - Li , et al. August 15, 2	2017-08-15
Heterocyclylamines as PI3K inhibitors Grant 9,707,233 - Li , et al. July 18, 2	2017-07-18
Bicyclic Heterocycles As Bet Protein Inhibitors App 20170014418 - Yue; Eddy W. ; et al.	2017-01-19
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors Grant 9,399,640 - Yue , et al. July 26, 2	2016-07-26
Heterocyclylamines As Pi3k Inhibitors App 20160022685 - Li; Yun-Long ; et al.	2016-01-28
Heterocyclylamines As Pi3k Inhibitors App 20160024117 - Li; Yun-Long ; et al.	2016-01-28
Heterocyclylamines as PI3K inhibitors Grant 9,199,982 - Li , et al. December 1, 2	2015-12-01
Bicyclic Heterocycles As Bet Protein Inhibitors App 20150148342 - Yue; Eddy W. ; et al.	2015-05-28
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20140249132 - Li; Yun-Long ; et al.	2014-09-04
Heterocyclylamines As Pi3k Inhibitors App 20130059835 - Li; Yun-Long ; et al.	2013-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.